Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1991;83:1543-1556

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Califf, R. M.
Right arrow Articles by Harrelson-Woodlief, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Califf, R. M.
Right arrow Articles by Harrelson-Woodlief, L.

Circulation, Vol 83, 1543-1556, Copyright © 1991 by American Heart Association


ARTICLES

Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group

RM Califf, EJ Topol, RS Stack, SG Ellis, BS George, DJ Kereiakes, JK Samaha, SJ Worley, JL Anderson and L Harrelson-Woodlief
Department of Medicine, Duke University Medical Center, Durham, N.C. 27710.

Recent trials of myocardial reperfusion using single-agent thrombolytic therapy and sequential cardiac catheterization have supported a conservative approach to the patient with acute myocardial infarction. To evaluate combination thrombolytic therapy and the role of a previously untested strategy for the aggressive use of cardiac catheterization, we performed a multicenter clinical trial with a 3 x 2 factorial design in which 575 patients were randomly allocated to one of three drug regimens--tissue-type plasminogen activator (t-PA) (n = 191), urokinase (n = 190), or both (n = 194) - and one of two catheterization strategies--immediate catheterization with angioplasty for failed thrombolysis (n = 287) or deferred predischarge catheterization on days 5-10 (n = 288). Patients with contraindications to thrombolytic therapy, cardiogenic shock, or age of more than 75 years were excluded. Global left ventricular ejection fraction was well preserved and almost identical at predischarge catheterization (54%), regardless of the catheterization or thrombolytic strategy used (p = 0.98). Combination thrombolytic therapy was associated with a less complicated clinical course, most clearly documented by a lower rate of reocclusion (2%) compared with urokinase (7%) and t-PA (12%) (p = 0.04) and a lower rate of recurrent ischemia (25%) compared with urokinase (35%) and t-PA (31%). When a composite clinical end point (e.g., death, stroke, reinfarction, reocclusion, heart failure, or recurrent ischemia) was examined, combination thrombolytic therapy was associated with greater freedom from any adverse event (68%) compared with either single agent (urokinase, 55%; t-PA, 60%) (p = 0.04) and with a less complicated clinical course when the composite clinical end points were ranked according to clinical severity (p = 0.024). Early patency rates were greater with combination therapy, although predischarge patency rates after considering interventions to maintain patency were similar among drug regimens. No difference in bleeding complication rates was observed with any thrombolytic regimen. The aggressive catheterization strategy led to an overall early patency rate of 96% and a predischarge patency rate of 94% compared with a 90% predischarge patency in the conservative strategy (p = 0.065). The aggressive strategy improved regional wall motion in the infarct region (-2.16 SDs/chord) compared with deferred catheterization (-2.49 SDs/chord) (p = 0.004). More patients treated with the aggressive strategy were free from adverse outcomes (67% versus 55% in the conservative strategy, p = 0.004), and the clinical course was less complicated when the adverse outcomes were ranked according to severity (p = 0.016). No significant increase in use of blood products resulted from the aggressive strategy.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
CirculationHome page
G. W. Stone
Angioplasty Strategies in ST-Segment-Elevation Myocardial Infarction: Part II: Intervention After Fibrinolytic Therapy, Integrated Treatment Recommendations, and Future Directions
Circulation, July 29, 2008; 118(5): 552 - 566.
[Full Text] [PDF]


Home page
HeartHome page
E. Eeckhout
RESCUE PERCUTANEOUS CORONARY INTERVENTION: DOES THE CONCEPT MAKE SENSE?
Heart, May 1, 2007; 93(5): 632 - 638.
[Full Text] [PDF]


Home page
American Journal of Medical QualityHome page
C. S. Hollenbeak, J. P. Fitzgibbons, M. Rossi, D. L. Morris, and P. Stillman
The Impact of Percutaneous Coronary Interventions on Outcomes for Acute Myocardial Infarction in Pennsylvania
American Journal of Medical Quality, March 1, 2007; 22(2): 85 - 94.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
J.-P. Collet, G. Montalescot, M. Le May, M. Borentain, and A. Gershlick
Percutaneous Coronary Intervention After Fibrinolysis: A Multiple Meta-Analyses Approach According to the Type of Strategy
J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1326 - 1335.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. B. Borden and D. P. Faxon
Facilitated Percutaneous Coronary Intervention
J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1120 - 1128.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 8: Stabilization of the Patient With Acute Coronary Syndromes
Circulation, December 13, 2005; 112(24_suppl): IV-89 - IV-110.
[Full Text] [PDF]


Home page
CMAJHome page
W. J. Cantor, F. Brunet, C. P. Ziegler, A. Kiss, and L. J. Morrison
Immediate angioplasty after thrombolysis: a systematic review
Can. Med. Assoc. J., December 6, 2005; 173(12): 1473 - 1481.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 5: Acute Coronary Syndromes
Circulation, November 29, 2005; 112(22_suppl): III-55 - III-72.
[Full Text] [PDF]


Home page
Eur Heart JHome page
P. G. Steg, L. Francois, B. Iung, D. Himbert, P. Aubry, P. Charlier, H. Benamer, L. J. Feldman, and J.-M. Juliard
Long-term clinical outcomes after rescue angioplasty are not different from those of successful thrombolysis for acute myocardial infarction
Eur. Heart J., September 2, 2005; 26(18): 1831 - 1837.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Schomig, G. Ndrepepa, J. Mehilli, J. Dirschinger, S. G. Nekolla, C. Schmitt, S. Martinoff, M. Seyfarth, M. Schwaiger, A. Kastrati, et al.
A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction
J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2073 - 2079.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
K. Y. Lee, D. I. Kim, S. H. Kim, S. I. Lee, H. W. Chung, Y. W. Shim, S. M. Kim, and J. H. Heo
Sequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke
AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1470 - 1475.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. L. Grines and W. W. O'Neill
Rescue angioplasty: Does the concept need to be rescued?
J. Am. Coll. Cardiol., July 21, 2004; 44(2): 297 - 299.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
G. M. Tadros, M. A. Islam, A. Mirza, J. C. Blankenship, and E. A. Iliadis
Angiographic and Long-Term Outcomes of "Rescue" Stenting versus PTCA in Failed Thrombolysis in Acute Myocardial Infarction
Angiology, March 1, 2004; 55(2): 169 - 176.
[Abstract] [PDF]


Home page
Eur Heart JHome page
M. Gupta, W.-C. Chang, F. Van de Werf, C. B. Granger, W. Midodzi, G. Barbash, K. Pehrson, A. Oto, P. Toutouzas, P. Jansky, et al.
International differences in in-hospital revascularization and outcomes following acute myocardial infarction: A multilevel analysis of patients in ASSENT-2
Eur. Heart J., September 2, 2003; 24(18): 1640 - 1650.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
F. A. McAlister, S. E. Straus, D. L. Sackett, and D. G. Altman
Analysis and Reporting of Factorial Trials: A Systematic Review
JAMA, May 21, 2003; 289(19): 2545 - 2553.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Gabriel Steg, B. Iung, L. J Feldman, A. P Maggioni, U. Keil, J. Deckers, D. Cokkinos, K. A.A Fox, and for the ENACT investigators
Determinants of use and outcomes of invasive coronary procedures in acute coronary syndromes: results from ENACT
Eur. Heart J., April 1, 2003; 24(7): 613 - 622.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
The Task Force on the Management of Acute Myocardi, F. Van de Werf, D. Ardissino, A. Betriu, D. V. Cokkinos, E. Falk, K. A.A. Fox, D. Julian, M. Lengyel, F.-J. Neumann, et al.
Management of acute myocardial infarction in patients presenting with ST-segment elevation
Eur. Heart J., January 1, 2003; 24(1): 28 - 66.
[Full Text] [PDF]


Home page
HeartHome page
M. A de Belder
CORONARY DISEASE: Acute myocardial infarction: failed thrombolysis
Heart, January 1, 2001; 85(1): 104 - 112.
[Full Text]


Home page
ChestHome page
E. M. Ohman, R. A. Harrington, C. P. Cannon, G. Agnelli, J. A. Cairns, and J.W. Kennedy
Intravenous Thrombolysis in Acute Myocardial Infarction
Chest, January 1, 2001; 119(1_suppl): 253S - 277S.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Bar, J. Vainer, J. Stevenhagen, K. Neven, R. Aalbregt, T. Oude Ophuis, V. van Ommen, H. de Swart, E. de Muinck, W. Dassen, et al.
Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction
J. Am. Coll. Cardiol., July 1, 2000; 36(1): 51 - 58.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
L. E. Goldman and M. J. Eisenberg
Identification and Management of Patients with Failed Thrombolysis after Acute Myocardial Infarction
Ann Intern Med, April 4, 2000; 132(7): 556 - 565.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
O. Iqbal, H. Messmore, D. Hoppensteadt, J. Fareed, and W. Wehrmacher
State-of-the-Art Review : Thrombolytic Drugs in Acute Myocardial Infarction
Clinical and Applied Thrombosis/Hemostasis, January 1, 2000; 6(1): 1 - 13.
[PDF]


Home page
J Am Coll CardiolHome page
A. M. Ross, K. S. Coyne, J. S. Reiner, S. W. Greenhouse, C. Fink, A. Frey, E. Moreyra, M. Traboulsi, N. Racine, A. L. Riba, et al.
A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial
J. Am. Coll. Cardiol., December 1, 1999; 34(7): 1954 - 1962.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
F Vermeer, A J M O. Ophuis, E J v. Berg, L G Brunninkhuis, C J Werter, A G Boehmer, A H Lousberg, W R Dassen, and F W Bar
Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study
Heart, October 1, 1999; 82(4): 426 - 431.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. J. Scanlon, D. P. Faxon, A.-M. Audet, B. Carabello, G. J. Dehmer, K. A. Eagle, R. D. Legako, D. F. Leon, J. A. Murray, S. E. Nissen, et al.
ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration with the Society for Cardiac Angiography and Interventions
J. Am. Coll. Cardiol., May 1, 1999; 33(6): 1756 - 1824.
[Full Text] [PDF]


Home page
JAMAHome page
W. R. Hathaway, E. D. Peterson, G. S. Wagner, C. B. Granger, K. M. Zabel, K. S. Pieper, K. A. Clark, L. H. Woodlief, R. M. Califf, and for the GUSTO-I Investigators
Prognostic Significance of the Initial Electrocardiogram in Patients With Acute Myocardial Infarction
JAMA, February 4, 1998; 279(5): 387 - 391.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
W. Pickering, M. Brozovic, M. Dancy, and H. Cohen
Thrombolysis, With or Without Heparin, During the First Nine Weeks After Acute Myocardiat Infarction
Clinical and Applied Thrombosis/Hemostasis, July 1, 1997; 3(3): 183 - 189.
[Abstract] [PDF]


Home page
NEJMHome page
R. Collins, R. Peto, C. Baigent, and P. Sleight
Aspirin, Heparin, and Fibrinolytic Therapy in Suspected Acute Myocardial Infarction
N. Engl. J. Med., March 20, 1997; 336(12): 847 - 860.
[Full Text] [PDF]


Home page
NEJMHome page
L. Pilote, D. P. Miller, R. M. Califf, J. S. Rao, W. D. Weaver, and E. J. Topol
Determinants of the Use of Coronary Angiography and Revascularization after Thrombolysis for Acute Myocardial Infarction
N. Engl. J. Med., October 17, 1996; 335(16): 1198 - 1205.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Laperche, P. G. Steg, M. Dehoux, J. Benessiano, G. Grollier, E. Aliot, J.-M. Mossard, P. Aubry, D. Coisne, M. Hanssen, et al.
A Study of Biochemical Markers of Reperfusion Early After Thrombolysis for Acute Myocardial Infarction
Circulation, October 15, 1995; 92(8): 2079 - 2086.
[Abstract] [Full Text]


Home page
CirculationHome page
E. T. Hasche, C. Fernandes, S. B. Freedman, and R. W. Jeremy
Relation Between Ischemia Time, Infarct Size, and Left Ventricular Function in Humans
Circulation, August 15, 1995; 92(4): 710 - 719.
[Abstract] [Full Text]


Home page
CirculationHome page
K. L. Lee, L. H. Woodlief, E. J. Topol, W. D. Weaver, A. Betriu, J. Col, M. Simoons, P. Aylward, F. Van de Werf, and R. M. Califf
Predictors of 30-Day Mortality in the Era of Reperfusion for Acute Myocardial Infarction : Results From an International Trial of 41 021 Patients
Circulation, March 15, 1995; 91(6): 1659 - 1668.
[Abstract] [Full Text]


Home page
Med Decis MakingHome page
C. Maynard, H. P. Selker, J. R. Beshansky, J. L. Griffith, C. H. Schmid, R. M. Califf, R. B. D'Agostino, M. M. Laks, K. L. Lee, G. S. Wagner, et al.
The Exclusion of Women from Clinical Trials of Thrombolytic Therapy: Implications for Developing the Thrombolytic Predictive Instrument Database
Med Decis Making, February 1, 1995; 15(1): 38 - 43.
[Abstract] [PDF]


Home page
CirculationHome page
C. L. Grines, E. J. Topol, W. W. O'Neill, B. S. George, D. Kereiakes, H. R. Phillips, J. D. Leimberger, L. H. Woodlief, and R. M. Califf
Effect of Cigarette Smoking on Outcome After Thrombolytic Therapy for Myocardial Infarction
Circulation, January 15, 1995; 91(2): 298 - 303.
[Abstract] [Full Text]


Home page
CirculationHome page
K. B. Michels and S. Yusuf
Does PTCA in Acute Myocardial Infarction Affect Mortality and Reinfarction Rates? : A Quantitative Overview (Meta-Analysis) of the Randomized Clinical Trials
Circulation, January 15, 1995; 91(2): 476 - 485.
[Abstract] [Full Text]


Home page
NEJMHome page
The GUSTO Investigators
An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction
N. Engl. J. Med., September 2, 1993; 329(10): 673 - 682.
[Abstract] [Full Text]


Home page
NEJMHome page
C. L. Grines, K. F. Browne, J. Marco, D. Rothbaum, G. W. Stone, J. O'Keefe, P. Overlie, B. Donohue, N. Chelliah, G. C. Timmis, et al.
A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction
N. Engl. J. Med., March 11, 1993; 328(10): 673 - 679.
[Abstract] [Full Text]


Home page
NEJMHome page
F. Zijlstra, M. J. de Boer, J. Hoorntje, S. Reiffers, J. Reiber, and H. Suryapranata
A Comparison of Immediate Coronary Angioplasty with Intravenous Streptokinase in Acute Myocardial Infarction
N. Engl. J. Med., March 11, 1993; 328(10): 680 - 684.
[Abstract] [Full Text]


Home page
CirculationHome page
K. M. Choi, R. J. Kim, G. Gubernikoff, J. D. Vargas, M. Parker, and R. M. Judd
Transmural Extent of Acute Myocardial Infarction Predicts Long-Term Improvement in Contractile Function
Circulation, September 4, 2001; 104(10): 1101 - 1107.
[Abstract] [Full Text] [PDF]